214
Views
14
CrossRef citations to date
0
Altmetric
Review

Cancer vaccines targeting carcinoembryonic antigen: state-of-the-art and future promise

, &
Pages 617-629 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Luigi Aurisicchio, Arthur Fridman, Ansuman Bagchi, Elisa Scarselli, Nicola La Monica & Gennaro Ciliberto. (2014) A novel minigene scaffold for therapeutic cancer vaccines. OncoImmunology 3:1.
Read now
Pier-Luigi Lollini, Federica Cavallo, Carla De Giovanni & Patrizia Nanni. (2013) Preclinical vaccines against mammary carcinoma. Expert Review of Vaccines 12:12, pages 1449-1463.
Read now

Articles from other publishers (12)

Benjamin Wolfson & James W. Hodge. (2021) Next Generation Therapeutic Strateg‐Es: Evolving cancer immunotherapy through agents that Engage , Expand and Enable the anti‐tumor immune response . ImmunoMedicine 1:1.
Crossref
Ye Chen, Bin Li, Peng Lyu, Hang Fai Kwok, Lilin Ge & Qinan Wu. (2020) Boronate ester bond–based potentiometric aptasensor for screening carcinoembryonic antigen-glycoprotein using nanometer-sized CaCO3 with ion-selective electrode. Analytical and Bioanalytical Chemistry 413:4, pages 1073-1080.
Crossref
Huifang Liu, Xu Nie, Zhenchao Tian, Dan Chen, Xueli Chen, Qi Zeng & Xinyi Xu. (2020) Single-domain antibodies for radio nuclear imaging and therapy of esophageal squamous cell carcinoma: a narrative review. Journal of Bio-X Research 3:4, pages 135-143.
Crossref
Wan-Lun Yan, Kuan-Yin Shen, Chun-Yuan Tien, Yu-An Chen & Shih-Jen Liu. (2017) Recent progress in GM-CSF-based cancer immunotherapy. Immunotherapy 9:4, pages 347-360.
Crossref
Katy J. McCann, Ann Mander, Angelica Cazaly, Lindsey Chudley, Jana Stasakova, Stephen M. Thirdborough, Andrew King, Paul Lloyd-Evans, Emily Buxton, Ceri Edwards, Sarah Halford, Andrew Bateman, Ann O'Callaghan, Sally Clive, Alan Anthoney, Duncan I. Jodrell, Toni Weinschenk, Petra Simon, Ugur Sahin, Gareth J. Thomas, Freda K. Stevenson & Christian H. Ottensmeier. (2016) Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes. Clinical Cancer Research 22:19, pages 4827-4836.
Crossref
Dong Soo Lee, Yeon S. Kim, Chul S. Kay, Sung H. Kim, Chang D. Yeo, Jin W. Kim, Seung Joon Kim, Young K. Kim, Yoon H. Ko, Jin H. Kang & Kyo Y. Lee. (2016) Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer. Medicine 95:6, pages e2795.
Crossref
Cornelis J.M. Melief, Thorbald van Hall, Ramon Arens, Ferry Ossendorp & Sjoerd H. van der Burg. (2015) Therapeutic cancer vaccines. Journal of Clinical Investigation 125:9, pages 3401-3412.
Crossref
Joseph P. Balint, Elizabeth S. Gabitzsch, Adrian Rice, Yvette Latchman, Younong Xu, Gerald L. Messerschmidt, Arvind Chaudhry, Michael A. Morse & Frank R. Jones. (2015) Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer. Cancer Immunology, Immunotherapy 64:8, pages 977-987.
Crossref
Luigi AurisicchioGiuseppe RoscilliEmanuele MarraLaura LubertoRita ManciniNicola La MonicaGennaro Ciliberto. (2015) Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen. Human Gene Therapy 26:6, pages 386-398.
Crossref
Martin J. Scurr, Clare M. Brown, Diana F. Costa Bento, Gareth J. Betts, Brian I. Rees, Robert K. Hills, Awen Gallimore & Andrew Godkin. (2015) Assessing the Prognostic Value of Preoperative Carcinoembryonic Antigen-Specific T-Cell Responses in Colorectal Cancer. JNCI: Journal of the National Cancer Institute 107:4.
Crossref
Wieger J. Norde, Willemijn Hobo & Harry Dolstra. 2015. Resistance of Cancer Cells to CTL-Mediated Immunotherapy. Resistance of Cancer Cells to CTL-Mediated Immunotherapy 31 58 .
David Escors. (2014) Tumour Immunogenicity, Antigen Presentation, and Immunological Barriers in Cancer Immunotherapy. New Journal of Science 2014, pages 1-25.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.